Sodium ions bind to the ghrelin receptor and shift it toward its inactive state, reducing both baseline and ghrelin-stimulated signaling activity.
Negative allosteric modulatorSodium decreases both basal and ghrelin-stimulated receptor activity by shifting the receptor toward its inactive conformation
What the researchers found
Using a combination of sodium-23 NMR spectroscopy, molecular dynamics simulations, and mutagenesis experiments, researchers demonstrated that sodium ions bind to a conserved allosteric site on the ghrelin receptor (GHSR). This binding shifts the receptor's conformational equilibrium toward its inactive state, decreasing both basal (constitutive) activity and agonist-induced G protein activation.
The allosteric sodium site is conserved across class A GPCRs, but this study specifically characterized its functional impact on GHSR for the first time, establishing sodium as an integral component of the ghrelin signaling machinery.
Why it matters
The ghrelin receptor is a major drug target for appetite disorders, obesity, and growth hormone deficiency. Understanding that sodium naturally regulates this receptor could open new approaches to modulating hunger and metabolism — and may explain why dietary sodium intake affects appetite-related signaling pathways.
How the study worked
The researchers used multiple complementary techniques: 23Na-NMR to detect sodium binding to the receptor, molecular dynamics simulations to model sodium-receptor interactions at the atomic level, site-directed mutagenesis to confirm the binding site, and spectroscopic and functional G protein activation assays to measure the downstream effects of sodium binding on receptor activity.
What this study cannot tell us
The experiments were conducted using purified receptor in controlled laboratory conditions, not in living cells or organisms. The physiological relevance of sodium's allosteric effect on GHSR under normal cellular sodium concentrations remains to be fully validated. The study did not examine whether sodium's effect differs across different ghrelin receptor signaling pathways (biased agonism).
How to read the evidence
This is a rigorous mechanistic study published in Cell Reports using multiple complementary biophysical techniques. While it provides strong molecular-level evidence, the findings are from in vitro receptor studies and require physiological validation.
When this study was published
Published in 2023, this study represents recent progress in understanding GPCR allosteric regulation, a rapidly evolving field in pharmacology.
The bigger picture
Sodium's role as an allosteric regulator has been proposed for many GPCRs but proven for few. By demonstrating this mechanism for the ghrelin receptor specifically, this study contributes to our fundamental understanding of how peptide hormone receptors are regulated — and may influence future drug design targeting the ghrelin system for obesity, cachexia, and metabolic disorders.
Questions still open
- Do fluctuations in cellular sodium levels meaningfully change ghrelin signaling in vivo?
- Could drugs targeting the sodium allosteric site on GHSR offer a new approach to appetite regulation?
- Does this sodium sensitivity differ between the constitutively active and ligand-activated states of the ghrelin receptor?
Common questions
What is the ghrelin receptor and why does it matter?
Does eating salt affect my hunger through this mechanism?
Read the original research
Sodium is a negative allosteric regulator of the ghrelin receptor.
Cell reports, 42(4), 112320
Citation
Ferré, Guillaume; Gomes, Antoniel A S; Louet, Maxime; Damian, Marjorie; Bisch, Paulo M; Saurel, Olivier; Floquet, Nicolas; Milon, Alain; Banères, Jean-Louis. (2023). Sodium is a negative allosteric regulator of the ghrelin receptor.. Cell reports, 42(4), 112320. https://doi.org/10.1016/j.celrep.2023.112320